Boditech Med announced its performance for Q3 2021
Generated $37 million in Q3 2021 and Q3 YTD 2021 recorded $102.9 million
Boditech Med launches three types of diagnostic kits for cancer diseases
It can simultaneously measure major tumor markers in the field within 15 minutes using whole blood
Boditech Med has acquired export license for two Therapeutic Drug Monitoring (TDM) diagnostic kits
Expecting to increase the efficacy of the target drug and to reduce side effects with cost-effective system
Who We Are
Heading to Global Top 10 In-Vitro diagnostic Company, Boditech Med Inc
We Boditech Med have been focusing on developing key technologies of immune-diagnosis and molecular diagnosis to provide reliable In-Vitro diagnostic solutions for everyone at anywhere, and anytime.
We are constantly striving to become a global In-Vitro diagnostic company realizing the value of respect for life. And We wish to finally improve quality of life across the world.